Since expression of cell cycle regulatory kinase CDK6 is required for the proliferation and survival of Ph-positive ALL cells, palbociclib could potentially stop the proliferation and accelerate the apoptosis of ALL cells [27]. This evidence concerns the gene CDK6 and acute lymphoblastic leukemia.